286 related articles for article (PubMed ID: 1880254)
21. Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study.
Bentsen KD; Hørslev-Petersen K; Junker P; Juhl E; Lorenzen I
Liver; 1987 Apr; 7(2):96-105. PubMed ID: 3613881
[TBL] [Abstract][Full Text] [Related]
22. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity.
Ramadori G; Zöhrens G; Manns M; Rieder H; Dienes HP; Hess G; Meyer KH; Büschenfelde Z
Eur J Clin Invest; 1991 Jun; 21(3):323-30. PubMed ID: 1909636
[TBL] [Abstract][Full Text] [Related]
23. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
Lin DY; Chu CM; Sheen IS; Liaw YF
Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
[TBL] [Abstract][Full Text] [Related]
24. Etretinate administration reduces serum propeptide of type I procollagen level in patients with psoriasis.
Osada K; Seishima M; Mori S; Seishima M; Takemura M; Noma A
Br J Dermatol; 1994 Nov; 131(5):655-9. PubMed ID: 7999596
[TBL] [Abstract][Full Text] [Related]
25. Elevated serum aminoterminal procollagen type III peptide in methotrexate-induced hepatic fibrosis.
Fairris GM; Brooks B; Tanner A
Br J Dermatol; 1986 Apr; 114(4):520-1. PubMed ID: 3964554
[No Abstract] [Full Text] [Related]
26. Collagen metabolism in gynecologic patients: changes in the concentration of the aminoterminal propeptide of type III procollagen in serum.
Puistola U; Risteli L; Risteli J; Kauppila A
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1276-81. PubMed ID: 2220941
[TBL] [Abstract][Full Text] [Related]
27. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.
Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R
Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456
[TBL] [Abstract][Full Text] [Related]
28. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease.
Shahin M; Schuppan D; Waldherr R; Risteli J; Risteli L; Savolainen ER; Oesterling C; Abdel Rahman HM; el Sahly AM; Abdel Razek SM
Hepatology; 1992 Apr; 15(4):637-44. PubMed ID: 1551641
[TBL] [Abstract][Full Text] [Related]
29. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
Chalmers RJ; Kirby B; Smith A; Burrows P; Little R; Horan M; Hextall JM; Smith CH; Klaber M; Rogers S
Br J Dermatol; 2005 Mar; 152(3):444-50. PubMed ID: 15787812
[TBL] [Abstract][Full Text] [Related]
30. Is the aminoterminal propeptide of type III procollagen degraded in the liver? A study of type III procollagen peptide in serum during liver transplantation in pigs.
Bentsen KD; Boesby S; Kirkegaard P; Hansen CP; Jensen SL; Hørslev-Petersen K; Lorenzen I
J Hepatol; 1988 Apr; 6(2):144-50. PubMed ID: 3045193
[TBL] [Abstract][Full Text] [Related]
31. Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis.
Khan S; Subedi D; Chowdhury MM
Postgrad Med J; 2006 May; 82(967):353-4. PubMed ID: 16679477
[TBL] [Abstract][Full Text] [Related]
32. Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases.
Gressner AM; Tittor W; Negwer A; Pick-Kober KH
Clin Chim Acta; 1986 Dec; 161(3):249-58. PubMed ID: 3802532
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen and laminin P1 in Duchenne muscular dystrophy.
von Moers A; Danne T; Möller P; Scheffner D
Acta Paediatr; 1997 Apr; 86(4):377-80. PubMed ID: 9174223
[TBL] [Abstract][Full Text] [Related]
34. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
[TBL] [Abstract][Full Text] [Related]
35. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury.
Suou T; Yamada S; Kobayashi J; Hoshino U; Nishimuki E; Kawasaki H
Hepatology; 1993 Oct; 18(4):809-15. PubMed ID: 7691706
[TBL] [Abstract][Full Text] [Related]
36. Serum aminoterminal type III procollagen peptide. Relation to biosynthesis of collagen type III in experimentally induced granulation tissue in rats.
Hørslev-Petersen K; Kim KY; Pedersen LR; Bentsen KD; Uldbjerg N; Oxlund H; Garbarsch C; Hahn EG; Schuppan D; Lorenzen I
APMIS; 1988 Sep; 96(9):793-804. PubMed ID: 3048338
[TBL] [Abstract][Full Text] [Related]
37. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
[TBL] [Abstract][Full Text] [Related]
38. Liver biopsies and methotrexate: a time for reconsideration?
Zachariae H
J Am Acad Dermatol; 2000 Mar; 42(3):531-4. PubMed ID: 10688735
[No Abstract] [Full Text] [Related]
39. Evaluation of circulating type I procollagen propeptides in patients with Paget's disease of bone.
Bonnin MR; Moragues C; Nolla JM; Lirón FJ; Roig-Escofet D; Navarro MA
Clin Chem Lab Med; 1998 Jan; 36(1):53-5. PubMed ID: 9594087
[TBL] [Abstract][Full Text] [Related]
40. Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate.
Biasi D; Bambara LM; Carletto A; Casaril M; Capra F; Caramaschi P; Corrocher R
J Rheumatol; 1996 Mar; 23(3):453-4. PubMed ID: 8832981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
